MicrobiologybioRxivPreprint
LAVR-289, a New Orally Bioavailable Inhibitor of Adenovirus Replication in vitro and in vivo.
Charlotte Quentin-Froignant, Ann E. Tollefson, Anna Cline-Smith…·Franck Gallardo
This study evaluates LAVR-289, an acyclonucleoside phosphonate, showing potent antiviral activity against adenovirus in vitro and in vivo, with 100% survival in immunocompromised hamsters.
DOI 10.1101/2025.02.20.639236